cancer Archives

Pharmalot By Ed Silverman

Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others

Health By Lindsey Tanner — Associated Press

Cancer deaths among Black people drop, but still higher than other groups

In the Lab By Angus Chen

Cancer experts hail a molecular ‘black box’ that records how cells fly into tumor territory

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: A CEO’s arrest, Pfizer’s big deal, & Covid on the rise

In the Lab By Megan Molteni

Publication of the ‘Google Maps’ of human cells is a milestone. A pioneer of the project explains why

Adam's Take By Adam Feuerstein

It took years, but the failure of Northwest Bio’s brain cancer vaccine is now in the open

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: How cancer-killing cell therapies work, biotech’s endless downturn, & an FDA conundrum

Biotech By Adam Feuerstein

Nkarta studies of engineered natural killer cells show complete remissions in patients with blood cancers

Biotech By Jonathan Wosen

With milestones on the horizon, Guardant Health CEOs lay out their vision for cancer detection

Health By Angus Chen

Multiple myeloma is usually detected late. Some researchers think a precursor could help catch it early

D.C. Diagnosis By Nicholas Florko

Biogen’s head-scratching new lobbyist hire

Adam's Take By Adam Feuerstein

What Regeneron’s purchase of Checkmate Pharma says about the state of biotech

Hospitals By Bob Herman

Nation’s top cancer hospitals slap hefty markups on drugs, study says

Adam's Take By Adam Feuerstein

Cel-Sci’s CEO used private call to tip off select investors about cancer drug update

First Opinion By Harry Rhodes

FDA needs to follow through on its plan to ban carbadox in animal feed

Biotech By Adam Feuerstein

Good fortunes continue for Sierra Oncology with $1.9 billion acquisition by U.K. pharma giant Glaxo

Health By Angus Chen

Trying not one, but a three-drug combination to help engineered T cells fight cancer

Health By Angus Chen

Covid vaccines didn’t work for many cancer patients — but researchers are designing a new shot for them

Biotech By Matthew Herper

Giving immunotherapy before surgery prevents lung cancer from returning, study says

Health By Angus Chen

An mRNA vaccine boost may help CAR T-therapy treat solid cancers

Biotech By Adam Feuerstein

Natural killer cells, primed with an antibody, induce remissions in patients with advanced lymphoma

Health By Angus Chen

Lighting up cancer cells with pH-activated nanoparticles

Politics By Lev Facher

Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

Biotech By Jonathan Wosen

When a dire text message interrupted his talk, this doctor’s cancer research became painfully real

Exclusive By Lev Facher

Most Read

A Caribou CAR-T treatment, backed by Nobel-winning science, shows blood-cancer remissions in first data reveal

Roche anti-TIGIT cancer immunotherapy fails second clinical trial, raising doubts about drug class

Novartis suspends production of two cancer therapies over potential quality issues

Study uncovers clues to rise in uterine cancer death rates

Early cancer-detection market heats up as Guardant Health launches colon cancer test

The FDA needs to take another look at laser-based ‘vaginal rejuvenation’

Cancer survivor: Don’t forget that accolade when it comes to Ruth Bader Ginsburg’s remarkable life

23andMe had devastating news about my health. I wish a person had delivered it

All Coverage

Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others

Cancer deaths among Black people drop, but still higher than other groups

Cancer experts hail a molecular ‘black box’ that records how cells fly into tumor territory

Listen: A CEO’s arrest, Pfizer’s big deal, & Covid on the rise

Publication of the ‘Google Maps’ of human cells is a milestone. A pioneer of the project explains why

It took years, but the failure of Northwest Bio’s brain cancer vaccine is now in the open

Listen: How cancer-killing cell therapies work, biotech’s endless downturn, & an FDA conundrum

Nkarta studies of engineered natural killer cells show complete remissions in patients with blood cancers

With milestones on the horizon, Guardant Health CEOs lay out their vision for cancer detection

Multiple myeloma is usually detected late. Some researchers think a precursor could help catch it early

Biogen’s head-scratching new lobbyist hire

What Regeneron’s purchase of Checkmate Pharma says about the state of biotech

Nation’s top cancer hospitals slap hefty markups on drugs, study says

Cel-Sci’s CEO used private call to tip off select investors about cancer drug update

FDA needs to follow through on its plan to ban carbadox in animal feed

Good fortunes continue for Sierra Oncology with $1.9 billion acquisition by U.K. pharma giant Glaxo

Trying not one, but a three-drug combination to help engineered T cells fight cancer

Covid vaccines didn’t work for many cancer patients — but researchers are designing a new shot for them

Giving immunotherapy before surgery prevents lung cancer from returning, study says

An mRNA vaccine boost may help CAR T-therapy treat solid cancers

Natural killer cells, primed with an antibody, induce remissions in patients with advanced lymphoma

Lighting up cancer cells with pH-activated nanoparticles

Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

When a dire text message interrupted his talk, this doctor’s cancer research became painfully real

NIH’s cancer chief, Ned Sharpless, to step down